Ruxolitinib
(16,17-diacetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) benzoate
Also Known As: Ruxolitinib|AC1L1FJZ|estriol benzoate diacetate|CTK8H8273|CID3270|(3R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile|(16,17-diacetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) benzoate|941678-49-5
| Molecular Formula | C29H32O6 |
|---|---|
| Molecular Weight | 476.21988 g/mol |
| Exact Mass | 476.21988 |
Chemical Identifiers
| CAS Number | 941678-49-5 |
|---|---|
| SMILES | CC(=O)OC1CC2C3CCC4=C(C3CCC2(C1OC(=O)C)C)C=CC(=C4)OC(=O)C5=CC=CC=C5 |
Product Overview
Ruxolitinib (CAS 941678-49-5), with molecular formula C29H32O6 and molecular weight 476.21988 g/mol. IUPAC: (16,17-diacetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) benzoate.
Frequently Asked Questions
📚 Academic Support
Scientific research papers and technical documentation supporting this product for informed procurement decisions.
Technical Blog Article
Multi-source research profile: chemical properties, regulatory status, and sourcing guide for Ruxolitinib.
Browse Technical Blog →No research papers found for this product yet.
We continuously update our academic references. Check back soon!